First, we activated NF-κB signaling by TNF-α in NSCLC cell line, A549 cells, and found the expression of miR-224 was significantly increased in A549 cells with TNF-α treatment compared to without TNF-α treatment. The gene discussed is TNF; the disease is non-small cell lung carcinoma.